Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 118

    1.

    Microvascular haemodynamic reactions to insulin.

    Wiernsperger N, Bouskela E.

    J Physiol. 2009 Nov 1;587(Pt 21):5289; author reply 5291-2. No abstract available. PMID: 19880878 [PubMed - in process]Related articles

    3.

    Metabolic disturbances linked to obesity: the role of impaired tissue perfusion.

    Villela NR, Kramer-Aguiar LG, Bottino DA, Wiernsperger N, Bouskela E.

    Arq Bras Endocrinol Metabol. 2009 Mar;53(2):238-45.PMID: 19466216 [PubMed - in process]Related articlesFree article

    4.

    Microcirculation in obesity: an unexplored domain.

    Wiernsperger N, Nivoit P, Bouskela E.

    An Acad Bras Cienc. 2007 Dec;79(4):617-38. Review.PMID: 18066432 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin.

    Faure P, Wiernsperger N, Polge C, Favier A, Halimi S.

    Clin Sci (Lond). 2008 Feb;114(3):251-6.PMID: 17922677 [PubMed - indexed for MEDLINE]Related articles

    6.

    Microcirculation and the metabolic syndrome.

    Wiernsperger N, Nivoit P, De Aguiar LG, Bouskela E.

    Microcirculation. 2007 Jun-Jul;14(4-5):403-38. Review.PMID: 17613811 [PubMed - indexed for MEDLINE]Related articles

    7.

    Substitution of drinking water by fructose solution induces hyperinsulinemia and hyperglycemia in hamsters.

    Barros CM, Lessa RQ, Grechi MP, Mouço TL, Souza MG, Wiernsperger N, Bouskela E.

    Clinics (Sao Paulo). 2007 Jun;62(3):327-34.PMID: 17589675 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Sleep apnea is induced by a high-fat diet and reversed and prevented by metformin in non-obese rats.

    Ramadan W, Dewasmes G, Petitjean M, Wiernsperger N, Delanaud S, Geloen A, Libert JP.

    Obesity (Silver Spring). 2007 Jun;15(6):1409-18.PMID: 17557978 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.

    Kraemer de Aguiar LG, Laflor CM, Bahia L, Villela NR, Wiernsperger N, Bottino DA, Bouskela E.

    Diabet Med. 2007 Mar;24(3):272-9.PMID: 17263761 [PubMed - indexed for MEDLINE]Related articles

    10.

    Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin.

    Bellin C, de Wiza DH, Wiernsperger NF, Rösen P.

    Horm Metab Res. 2006 Nov;38(11):732-9.PMID: 17111300 [PubMed - indexed for MEDLINE]Related articles

    11.

    Obstructive sleep apnea and insulin resistance: a role for microcirculation?

    Wiernsperger N, Nivoit P, Bouskela E.

    Clinics (Sao Paulo). 2006 Jun;61(3):253-66. Epub 2006 Jun 30. Review.PMID: 16832559 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms?

    Masson E, Lagarde M, Wiernsperger N, El Bawab S.

    IUBMB Life. 2006 Jul;58(7):381-8. Review.PMID: 16801212 [PubMed - indexed for MEDLINE]Related articles

    13.

    Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.

    de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E.

    Diabetes Care. 2006 May;29(5):1083-9.PMID: 16644641 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.

    Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, Andreelli F, Viollet B, Hue L.

    Diabetes. 2006 Apr;55(4):865-74.PMID: 16567505 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.

    Rösen P, Wiernsperger NF.

    Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):323-30.PMID: 16444763 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process.

    Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N, Leverve X.

    Diabetes. 2005 Jul;54(7):2179-87.PMID: 15983220 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Albumin antioxidant capacity is modified by methylglyoxal.

    Faure P, Troncy L, Lecomte M, Wiernsperger N, Lagarde M, Ruggiero D, Halimi S.

    Diabetes Metab. 2005 Apr;31(2):169-77.PMID: 15959423 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels.

    Geoffroy K, Troncy L, Wiernsperger N, Lagarde M, El Bawab S.

    FEBS Lett. 2005 Feb 14;579(5):1249-54. Epub 2005 Jan 22.PMID: 15710421 [PubMed - indexed for MEDLINE]Related articles

    22.

    Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.

    Masson E, Wiernsperger N, Lagarde M, El Bawab S.

    Biochem J. 2005 Jun 1;388(Pt 2):537-44.PMID: 15654767 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.

    Masson E, Wiernsperger N, Lagarde M, El Bawab S.

    Glycobiology. 2005 Jun;15(6):585-91. Epub 2004 Dec 29.PMID: 15625180 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?

    Masson E, Troncy L, Ruggiero D, Wiernsperger N, Lagarde M, El Bawab S.

    Diabetes. 2005 Jan;54(1):220-7.PMID: 15616032 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Noninvasive orthogonal polarization spectral imaging as applied to microvascular studies in mice.

    Nivoit P, Chevrier AM, Lagarde M, Renaudin C, Wiernsperger N.

    Exp Diabesity Res. 2004 Jul-Sep;5(3):211-7.PMID: 15512789 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Involvement of caspase-10 in advanced glycation end-product-induced apoptosis of bovine retinal pericytes in culture.

    Lecomte M, Denis U, Ruggiero D, Lagarde M, Wiernsperger N.

    Biochim Biophys Acta. 2004 Aug 4;1689(3):202-11.PMID: 15276646 [PubMed - indexed for MEDLINE]Related articles

    27.

    Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids.

    Geoffroy K, Wiernsperger N, Lagarde M, El Bawab S.

    J Biol Chem. 2004 Aug 13;279(33):34343-52. Epub 2004 Jun 7.PMID: 15184394 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase.

    Holland W, Morrison T, Chang Y, Wiernsperger N, Stith BJ.

    Biochem Pharmacol. 2004 Jun 1;67(11):2081-91.PMID: 15135305 [PubMed - indexed for MEDLINE]Related articles

    29.

    Oxidative stress: the special case of diabetes.

    Wiernsperger NF.

    Biofactors. 2003;19(1-2):11-8. Review.PMID: 14757973 [PubMed - indexed for MEDLINE]Related articles

    30.

    Oxidative stress as a therapeutic target in diabetes: revisiting the controversy.

    Wiernsperger NF.

    Diabetes Metab. 2003 Dec;29(6):579-85. Review.PMID: 14707886 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

    Nivoit P, Wiernsperger N, Moulin P, Lagarde M, Renaudin C.

    Diabetologia. 2003 Nov;46(11):1550-8. Epub 2003 Oct 24.PMID: 14576982 [PubMed - indexed for MEDLINE]Related articles

    32.

    The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors.

    Vailhé B, Lecomte M, Wiernsperger N, Tranqui L.

    Angiogenesis. 1998;2(4):331-44.PMID: 14517453 [PubMed]Related articles

    33.

    Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.

    Leverve XM, Guigas B, Detaille D, Batandier C, Koceir EA, Chauvin C, Fontaine E, Wiernsperger NF.

    Diabetes Metab. 2003 Sep;29(4 Pt 2):6S88-94. Review.PMID: 14502105 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Microcirculation in insulin resistance and diabetes: more than just a complication.

    Wiernsperger NF, Bouskela E.

    Diabetes Metab. 2003 Sep;29(4 Pt 2):6S77-87. Review.PMID: 14502104 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Antiatherogenic properties of metformin: the experimental evidence.

    Mamputu JC, Wiernsperger NF, Renier G.

    Diabetes Metab. 2003 Sep;29(4 Pt 2):6S71-6. Review.PMID: 14502103 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Metformin and its liver targets in the treatment of type 2 diabetes.

    Radziuk J, Bailey CJ, Wiernsperger NF, Yudkin JS.

    Curr Drug Targets Immune Endocr Metabol Disord. 2003 Jun;3(2):151-69. Review.PMID: 12769787 [PubMed - indexed for MEDLINE]Related articles

    37.

    Mild acute renal failure potentiates metformin accumulation in the diabetic rat kidney without further impairment of renal function.

    Barthelmebs M, Wiernsperger N, Krieger JP, Rapin JR, Radziuk J, Grima M, Imbs JI.

    Diabetes Metab. 2003 Apr;29(2 Pt 1):163-70.PMID: 12746638 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Differential effects of metformin on bile salt absorption from the jejunum and ileum.

    Carter D, Howlett HC, Wiernsperger NF, Bailey CJ.

    Diabetes Obes Metab. 2003 Mar;5(2):120-5.PMID: 12630937 [PubMed - indexed for MEDLINE]Related articles

    39.

    Effects of metformin on bile salt transport by monolayers of human intestinal Caco-2 cells.

    Carter D, Howlett HC, Wiernsperger NF, Bailey C.

    Diabetes Obes Metab. 2002 Nov;4(6):424-7.PMID: 12406042 [PubMed - indexed for MEDLINE]Related articles

    40.

    Increased intraabdominal adipose tissue mass in fructose fed rats: correction by metformin.

    Baret G, Peyronnet J, Grassi-Kassisse D, Dalmaz Y, Wiernsperger N, Géloën A.

    Exp Clin Endocrinol Diabetes. 2002 Sep;110(6):298-303.PMID: 12373634 [PubMed - indexed for MEDLINE]Related articles

    41.

    Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction.

    Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M.

    Free Radic Biol Med. 2002 Jul 15;33(2):236-47.PMID: 12106819 [PubMed - indexed for MEDLINE]Related articles

    42.

    In vivo kinetics of 123 iodine-labelled insulin in skeletal muscle of patients with type 2 diabetes. Effect of metformin.

    Valensi P, Behar A, Cohen-Boulakia F, Valensi J, Wiernsperger N, Attali JR.

    Diabetes Metab. 2002 Apr;28(2):95-103.PMID: 11976561 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function.

    Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P.

    Biochem Pharmacol. 2002 Apr 1;63(7):1259-72.PMID: 11960602 [PubMed - indexed for MEDLINE]Related articles

    44.

    In defense of microvascular constriction in diabetes.

    Wiernsperger NF.

    Clin Hemorheol Microcirc. 2001;25(2):55-62. Review.PMID: 11790871 [PubMed - indexed for MEDLINE]Related articles

    45.

    Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet.

    Mithieux G, Guignot L, Bordet JC, Wiernsperger N.

    Diabetes. 2002 Jan;51(1):139-43.PMID: 11756333 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Metformin: intrinsic vasculoprotective properties.

    Wiernsperger NF.

    Diabetes Technol Ther. 2000 Summer;2(2):259-72. Review. No abstract available. PMID: 11469268 [PubMed - indexed for MEDLINE]Related articles

    47.

    Glycosphingolipid changes induced by advanced glycation end-products.

    Natalizio A, Ruggiero D, Lecomte M, Lagarde M, Wiernsperger N.

    Biochem Biophys Res Commun. 2001 Feb 16;281(1):78-83.PMID: 11178963 [PubMed - indexed for MEDLINE]Related articles

    48.

    The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis.

    Chu CA, Wiernsperger N, Muscato N, Knauf M, Neal DW, Cherrington AD.

    Metabolism. 2000 Dec;49(12):1619-26.PMID: 11145127 [PubMed - indexed for MEDLINE]Related articles

    49.

    Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon?

    Wiernsperger N.

    Diabetologia. 2000 Nov;43(11):1439-48. Review. No abstract available. PMID: 11126416 [PubMed - indexed for MEDLINE]Related articles

    50.

    Vascular permeability increase as induced by histamine or bradykinin is enhanced by advanced glycation endproducts (AGEs).

    Svensjö E, Cyrino F, Michoud E, Ruggiero D, Bouskela E, Wiernsperger N.

    J Diabetes Complications. 1999 Jul-Aug;13(4):187-90.PMID: 10616857 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...